Yahoo MoviesDe'Aaron Fox with an and one vs the LA Clippers
De'Aaron Fox (Sacramento Kings) with an and one vs the LA Clippers, 01/20/2021
De'Aaron Fox (Sacramento Kings) with an and one vs the LA Clippers, 01/20/2021
You can never have too much chocolate.
Ireland expects to receive its first doses of the Johnson & Johnson COVID-19 vaccine from mid-April and not early April as initially planned, the head of the country's health service operator said on Tuesday. J&J's vaccine, which requires only one dose for protection, is expected to be approved on March 11 for use in the European Union by the bloc's regulator. In an updated roll-out plan published last month, Ireland forecast that it would receive 602,000 J&J shots in the second quarter - around 15% of its total quarterly supply - and would start administering the vaccine in the first week of April.
An Emerging Markets Sponsored Commentary ORLANDO, Fla., March 09, 2021 (GLOBE NEWSWIRE) -- Last month we introduced our readership to XPhyto Therapeutics Corp. (XPHYF). At such time, we mentioned that the Company is also involved in psychedelics and that we would dive into that matter at a later date. Today’s that date. For the uninitiated, psychedelic companies have been enjoying increased interest in North American stock markets as research portends significant possible clinical use. Take a look at this article from Forbes. Here’s a brief excerpt: “Like cannabis, the psychedelics industry has been growing at a locomotive pace. A key reason is an intriguing trend within the mental health community: the evolving acceptance of psychedelic drugs for treating depression and other mental disorders. XPhyto has a world view, having published a couple significant psychedelic benchmark releases in February 2021 alone. Take a look: XPhyto Announces Psychedelic Pharmaceutical Production Agreement XPhyto Laboratories Inc, its wholly owned Alberta subsidiary, has signed an agreement with Applied Pharmaceutical Innovation ("Applied") for the synthesis of pharmaceutical grade psychedelic compounds and the parallel development of the standard operating procedures necessary to obtain regulatory approval for the respective commercial production process. The industrial-scale production of standardized active pharmaceutical ingredients is an important part of XPhyto's psychedelic pharmaceutical program as the Company anticipates a shortage of large-scale supply of certain approved and standardized pharmaceutical grade psychedelics. Source link here. XPhyto Adds Mescaline Production to Psychedelic Medicine Programs XPhyto Therapeutics Corp. is pleased to announce that XPhyto Laboratories Inc., its wholly owned Alberta subsidiary, has added mescaline production to its psychedelic medicine programs. Further to the Company's press release dated February 3, 2021, the capacity under contract with Applied Pharmaceutical Innovation will focus on the synthesis of pharmaceutical grade mescaline. Mescaline has been anecdotally recognized as a relatively safe psychedelic drug and has shown particular promise for the treatment of addiction and depression. FYI, this is in addition to the Company’s European-based psilocybin biotechnology production development. It’s a considerable footprint in the psychedelic market, especially with the seminal legalization efforts in Oregon in late 2020. About XPhyto Therapeutics Corp. XPhyto Therapeutics Corp. is a bioscience accelerator focused on next-generation drug delivery, diagnostic, and new active pharmaceutical ingredient investment opportunities, including: precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications, including psychedelic compounds and cannabinoids. The Company has research and development operations in North America and Europe and is currently focused on regulatory approval and commercialization of medical products for European markets. About The Emerging Markets Report: The Emerging Markets Report is owned and operated by Emerging Markets Consulting (“EMC”), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets. For more informative reports such as this, please sign up at http://www.emergingmarketsllc.com/newsletter.php. Must Read OTC Markets/SEC policy on stock promotion and investor protectionhttps://www.otcmarkets.com/learn/policy-on-stock-promotionhttps://www.otcmarkets.com/learn/investor-protectionhttps://www.sec.gov/news/press-release/2017-79https://www.sec.gov/oiea/investor-alerts-bulletins/ia_promotions.html Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below. We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies. The best source for full disclosure about the company is the company itself, SEDAR or CSE profile pages for regulatory filings and news releases. EMC has been paid $150,000 by XPhyto Therapeutics Corp. for various marketing services including this report. EMC does not independently verify any of the content linked-to from this editorial. http://emergingmarketsllc.com/disclaimer.php. Emerging Markets Consulting, LLCFlorida Office390 North Orange Ave Suite 2300Orlando, FL 32801E-mail: jamespainter@emergingmarketsllc.comWeb: www.emergingmarketsllc.com
ORLANDO, Fla., March 09, 2021 (GLOBE NEWSWIRE) -- In real estate investing the axiom “Location, Location, Location” has long been an axion. For nascent public companies, the mantra may well be “Revenue, Revenue, Revenue.” Real revenue, even in smaller amounts, does a number of incredibly positive things for small cap companies. Chief among them is that revenue helps prove that there is a market for a product or service. On top of that, revenue is imperative for companies at this early point in their development as it helps sustain operations while fueling growth and future opportunity. And perhaps paramount among the benefits, revenue can greatly decrease or deflect dangerous toxic debt that is so often the death knell of a small cap company. To that end, American Aires Inc. (CSE: WIFI) (OTC: AAIRF) a nanotechnology-focused disruptor focused on developing products that reduce the harmful effects of electromagnetic radiation ("EMR") emitted by everyday consumer electronic devices, has had a pretty good month. First, the Company reported record revenue growth of over 300% in the fourth quarter of 2020 relative to the same period the prior year based on preliminary and unaudited numbers. Three hundred percent. Adding to that garish number is news of a planned market expansion, which if successful, would obviously yield even more revenue. A short time ago American Aires announced the implementation of an innovative new marketing initiative for 2021, comprised of a drop shipping program which includes online retailers and a complementary marketing campaign. Topping all this off is interesting news about a new recurring revenue subscription model which once deployed will provide an additional purchasing option for customers through the implementation of a multi-year subscription plan for Aires products. This new subscription plan is a way to generate a worry-free, predictable revenue stream for Aires and, most importantly, is a way of building strong relationships with customers. About American Aires, Inc: American Aires Inc. is a nanotechnology company which has developed proprietary silicon-based microprocessors that reduce the harmful effects of electromagnetic radiation (EMR). The technology was developed by a team of highly credited scientists and confirmed by independent third-party validation including peer reviewed studies and publications in scientific journals. The technology specifically targets cellphones, computers, baby monitors, Wi-Fi radiation and general EMR emitted by consumer electronic devices. About The Emerging Markets Report: The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets. For more informative reports such as this, please sign up at http://www.emergingmarketsllc.com/newsletter.php Must Read OTC Markets/SEC policy on stock promotion and investor protection https://www.otcmarkets.com/learn/policy-on-stock-promotionhttps://www.otcmarkets.com/learn/investor-protectionhttps://www.sec.gov/news/press-release/2017-79https://www.sec.gov/oiea/investor-alerts-bulletins/ia_promotions.html Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below. We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies. EMC has been paid $300,000 by American Aires, Inc. for various marketing services including this report. EMC does not independently verify any of the content linked-to from this editorial. http://emergingmarketsllc.com/disclaimer.php Emerging Markets Consulting, LLCFlorida Office390 North Orange Ave Suite 2300,Orlando FL U.S.A. 32801E-mail: jamespainter@emergingmarketsllc.comWeb: www.emergingmarketsllc.com
An Emerging Markets Sponsored Commentary ORLANDO, Fla., March 09, 2021 (GLOBE NEWSWIRE) -- Significant news release from diversified health and wellness; beverage and natural products company, BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) last week as the Company appointed Melise Panetta as its new President. Chief among Panetta’s resume stops is a tenure as an executive at beverage giant PepsiCo. We think this is a very notable event. Let’s show you why. With BevCanna’s recent transformative acquisition(s), its evident CPG and cannabis-infused beverages and natural products are going to be significant driving factors going forward. Adding an executive of Panetta’s standing can be highly catalytic to growth... and notoriety. Let’s start with the latter. Adding Panetta, a leading consumer packaged goods ("CPG") executive who has held senior and executive roles at global companies such as General Mills, PepsiCo, and S.C. Johnson says a lot about the quality and growth prospect of the organization. Ms. Panetta has seen beverage and CPG companies of the highest order and for her to join BevCanna at this stage, shows how she views its potential trajectory. By inking Panetta, we believe, BevCanna gets a myriad of leadership benefits coming to the big chair as well as a real mark of notoriety. Factor in that she has broad experience in the cannabis sector as well and the implied benefits grow clearer. The release is chocked full of nuggets that we like: “Melise joined the team in the fall to build our international commercial strategy” or “We’ve already capitalized on her significant expertise to accelerate our strategic planning for the newly amalgamated company.” And of course, this hefty release doesn’t touch on what Ms. Panetta could hypothetically do with her industry Rolodex via deals with larger partners and/or even recruiting for the BevCanna team. Again, 100% hypothetical but this is what presidents of companies often do.Nonetheless, in this important release from BevCanna perhaps the most important line comes from the new president herself who says unequivocally that “This is a truly transformative time for BevCanna." About The Emerging Markets Report: The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets. For more informative reports such as this, please sign up at http://www.emergingmarketsllc.com/newsletter.php Must Read OTC Markets/SEC policy on stock promotion and investor protection https://www.otcmarkets.com/learn/policy-on-stock-promotionhttps://www.otcmarkets.com/learn/investor-protectionhttps://www.sec.gov/news/press-release/2017-79https://www.sec.gov/oiea/investor-alerts-bulletins/ia_promotions.html Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below. We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies. EMC has been paid $350,000 by BevCanna Enterprises Inc. for various marketing services including this report. EMC does not independently verify any of the content linked-to from this editorial. http://emergingmarketsllc.com/disclaimer.php Emerging Markets Consulting, LLCFlorida Office390 North Orange Ave Suite 2300Orlando Fl, 32801E-mail: jamespainter@emergingmarketsllc.comWeb: www.emergingmarketsllc.com
Some viewers are calling for the weather presenter to take over as host of the show after he confronted Piers Morgan over his Meghan Markle vendetta.
The phishing mails usually carried a link to a phishing website that promised early access to vaccinations in exchange for a payment.
Keeping schools closed or even partially closed, based on what we know now, is harming children.
Assurant to Sell Global Preneed to CUNA Mutual Group for $1.3 Billion.
PETAH TIKVA, Israel, March 09, 2021 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announces the appointment of Isaac Angel as Gilat's Chairman of the Board. Isaac Angel's appointment is effective immediately, taking over from Dov Baharav who has stepped down and retired after a seven-year tenure. Isaac Angel brings with him a wealth of experience and accomplishments from his current and previous positions. Mr. Angel serves as Chairman of the Board and served as CEO at Ormat Technologies Inc., a global company delivering renewable power and energy solutions. Before his seven-year tenure as an officer and director at Ormat, Mr. Angel held executive positions at LeadCom Integrated Solutions, VeriFone and Lipman Electronic Engineering Ltd. "On behalf of Gilat, I would like to welcome Mr. Angel to Gilat and am very much looking forward to working together and benefiting from his extensive experience in a growing global company," said Adi Sfadia, Gilat's CEO. "We are expecting that 2021 will be a year of growth and opportunities coming out of the COVID-19 pandemic and have no doubts that Mr. Angel's vast experience will have an invaluable contribution to Gilat." "Gilat has over thirty years of impressive global expertise, a strong customer base, outstanding innovative technology and talented employees, which well-positions Gilat for profitable growth," said Isaac Angel, Gilat's Chairman of the Board. "I am confident that the Board will continue to successfully guide Gilat and play a significant part in its future accomplishments." About GilatGilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT) is a leading global provider of satellite-based broadband communications. With 30 years of experience, we design and manufacture cutting-edge ground segment equipment, and provide comprehensive solutions and end-to-end services, powered by our innovative technology. Delivering high value competitive solutions, our portfolio comprises of a cloud based VSAT network platform, high-speed modems, high performance on-the-move antennas and high efficiency, high power Solid State Amplifiers (SSPA) and Block Upconverters (BUC). Gilat’s comprehensive solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense and public safety, all while meeting the most stringent service level requirements. Gilat controlling shareholders are the FIMI Private Equity Funds. For more information, please visit: www.gilat.com Certain statements made herein that are not historical are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “estimate”, “project”, “intend”, “expect”, “believe” and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties. Many factors could cause the actual results, performance or achievements of Gilat to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, among others, risks associated with the outbreak and global spread of the coronavirus (COVID-19) pandemic; changes in general economic and business conditions, inability to maintain market acceptance to Gilat’s products, inability to timely develop and introduce new technologies, products and applications, rapid changes in the market for Gilat’s products, loss of market share and pressure on prices resulting from competition, introduction of competing products by other companies, inability to manage growth and expansion, loss of key OEM partners, inability to attract and retain qualified personnel, inability to protect the Company’s proprietary technology and risks associated with Gilat’s international operations and its location in Israel. For additional information regarding these and other risks and uncertainties associated with Gilat’s business, reference is made to Gilat’s reports filed from time to time with the Securities and Exchange Commission. We undertake no obligation to update or revise any forward-looking statements for any reason. Contact:Gilat Satellite NetworksDoreet Oren, Director Corporate CommunicationsDoreetO@gilat.com GK Investor and Public RelationsEhud Helft, Managing Partnerehud@gkir.com
NEW YORK, March 09, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, has been invited to participate at the 33rd Annual ROTH Growth Conference being held virtually on March 15-17, 2021. The conference will feature presentations from public and private companies across a variety of industry sectors, followed by one-on-one and small group meetings, as well as expert panels and fireside chats. Past events have featured more than 550 participating companies and drawn more than 5,000 attendees, including institutional investors, analysts, family offices and high-net-worth investors. LifeMD CEO Justin Schreiber will participate in one-on-one meetings with investors and analysts during the conference. He will be joined by the company’s CFO, Marc Benathen, and chief business officer, Corey Deutsch. Management will discuss the upcoming official launch of the company’s new subscription-based primary care and concierge telehealth services, which represents another valuable avenue for attracting new patients to the LifeMD digital health platform and expanding the company’s offerings to existing patients. The company recently announced it expects Q1 2021 revenues to exceed $17 million, up more than 295% compared to Q1 2020. Subscriptions are expected to generate more than 80% of revenue in the quarter, compared to about 63% in the same year-ago period. To submit a registration request, click here. To schedule a one-on-one meeting with LifeMD, please contact your ROTH representative. For any questions about the company, contact Ron Both of CMA at (949) 432-7557 or submit your request here. About ROTH Capital PartnersROTH Capital Partners, LLC “ROTH” is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, ROTH provides capital raising, M&A advisory, analytical research, trading, market-making services and corporate access. Headquartered in Newport Beach, CA, ROTH is privately held and employee owned. For more information on ROTH, please visit www.roth.com. About LifeMDLifeMD, Inc. (formerly Conversion Labs) is a leading telehealth company that is transforming the healthcare landscape with direct-to-patient product and service offerings. LifeMD's telemedicine platform enables virtual access to affordable and convenient medical treatment from licensed providers and, when appropriate, prescription medications and over-the-counter products delivered directly to the patient's home. To learn more, go to LifeMD.com. About Annual Recurring RevenueThe company calculates its annual recurring revenue (ARR) by multiplying by 12 the monthly sum of revenue attributed exclusively to automatic subscription sales from customers that are engaged in the company’s rebill structure as it applies to its main brands: Shapiro MD, Rex MD and PDFSimpli. In the company’s calculation of ARR, it does not consider single sales from customers that repurchase its products through the company’s standard checkout pages, Amazon Marketplace or involving the assistance of a customer service representatives. It also does not include revenue from the initial purchase of a new subscriber. Important Cautions Regarding Forward-Looking StatementsThis news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things our plans, strategies and prospects -- both business and financial. Although we believe that our plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Many of the forward-looking statements contained in this news release may be identified by the use of forward-looking words such as "believe," "expect," "anticipate," "should," "planned," "will," "may," "intend," "estimated," and "potential," among others. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include market conditions and those set forth in reports or documents that we file from time to time with the United States Securities and Exchange Commission. All forward-looking statements attributable to LifeMD, Inc. or a person acting on its behalf are expressly qualified in their entirety by this cautionary language. LifeMD™, Shapiro MD™, Rex MD™ and Nava MD™ are trademarks of LifeMD. All other trademarks are the property of their respective owners. Company Contact LifeMD, Inc. Marc Benathen, CFOEmail Contact Media and Investor Relations ContactRon Both or Grant StudeCMA Investor RelationsTel (949) 432-7566Email Contact
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) ("HempFusion" or the "Company"), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its OTC Topical Products have ranked number one in both sales dollars and units sold at a major Food & Drug Mass ("FDM") retailer according to a recent NielsenIQ share report.
Under the Chinese Law, intelligence agencies enjoy wide powers vis-Ă -vis all individuals and organisations.
A Minneapolis judge planned to begin screening jurors on Tuesday in the trial of Derek Chauvin, the former policeman facing criminal charges for his role in the death of George Floyd during an arrest that caused an outcry around the world. The trial is seen as a landmark case on police violence against Black people in the United States, a country where police officers are rarely found to be criminally responsible for killing civilians. Chauvin's lawyers are asking the state Supreme Court to prevent the additional charge being applied.
BERLIN — Germany coach Joachim Löw will step down after this year's European Championship, bringing forward his previous plan to quit after the next World Cup. The German soccer federation said Tuesday that Löw asked to terminate his contract, which was to run through the 2022 World Cup, after this year's European tournament. Löw is the longest-serving coach of a national team and has been in charge for 189 games. He took over after the 2006 World Cup and had been assistant coach to Jürgen Klinsmann for two years before that. “I’m taking this step very consciously, full of pride and with gratitude, but still with the same motivation for the upcoming European Championship,” Löw said. “Pride, because it is something very special for me and an honour to be engaged for my country. And because I have been able to work with the best players in the country for almost 17 years.” Löw led Germany to the 2014 World Cup title, its fourth overall, but he has been under pressure since a first-round exit at the last World Cup and subsequent lacklustre performances. Löw wanted a shake-up of the team after the disappointing World Cup in Russia, and he axed the experienced trio Thomas Müller, Jérôme Boateng and Mats Hummels to make room for younger players. But they haven't been able to make the step up. Germany produced one disjointed performance after another last year with laboured wins over Ukraine and the Czech Republic. It conceded late equalizers against Spain, Switzerland and Turkey before the team's last game ended in a 6-0 loss to the Spanish in the Nations League in November. That was Germany's biggest losing margin since a 6-0 result against Austria in a friendly in Berlin in 1931. “Big triumphs and painful defeats, but above all many wonderful and magic moments — not only the 2014 World Cup win in Brazil," Löw said. "I will remain thankful to the federation for always providing myself and the team an optimal working environment.” Federation president Fritz Keller said Löw's decision to quit after the European Championship is “highly respectable” because it gives the governing body “the necessary time to name his successor calmly and with a sense of proportion.” Keller thanked the 61-year-old Löw for his service. “The federation knows what it has in Jogi. He is one of the biggest coaches in world soccer,” Keller said. “Jogi Löw has shaped German soccer like none other for years and helped it to the highest levels internationally.” Löw said he would do all he can at the European Championship, which was postponed last year because of the coronavirus pandemic. Germany has been drawn in a group with World Cup champion France, European champion Portugal and Hungary. “I'll give my best," Löw said, "to make our fans happy and to be successful at this tournament.” ___ More AP soccer: https://apnews.com/hub/soccer and https://twitter.com/AP_Sports ___ Ciarán Fahey on Twitter: https://twitter.com/cfaheyAP CiaráN Fahey, The Associated Press
LEVUEN, Belgium (AP) _ Materialise NV (MTLS) on Tuesday reported a fourth-quarter loss of $2.6 million, after reporting a profit in the same period a year earlier. The 3D printing software and medical and industrial products company posted revenue of $55.6 million in the period. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research.
Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 8. - Influencer Pool: 896. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.New York, March 09, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Vehicles for Disabled Industry" - https://www.reportlinker.com/p06033228/?utm_source=GNW In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack. - Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations. Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations. Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives. Abstract: - Global Vehicles for Disabled Market to Reach $5.9 Billion by 2027 - Amid the COVID-19 crisis, the global market for Vehicles for Disabled estimated at US$2.8 Billion in the year 2020, is projected to reach a revised size of US$5.9 Billion by 2027, growing at a CAGR of 11% over the analysis period 2020-2027. Mobility Scooter, one of the segments analyzed in the report, is projected to record a 11.8% CAGR and reach US$2.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Passenger Cars segment is readjusted to a revised 11% CAGR for the next 7-year period. - The U.S. Market is Estimated at $836.3 Million, While China is Forecast to Grow at 10.5% CAGR - The Vehicles for Disabled market in the U.S. is estimated at US$836.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1 Billion by the year 2027 trailing a CAGR of 10.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.7% and 9.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.9% CAGR. - SUV / MPV Segment to Record 9.6% CAGR - In the global SUV / MPV segment, USA, Canada, Japan, China and Europe will drive the 9.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$385.2 Million in the year 2020 will reach a projected size of US$723.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$687.9 Million by the year 2027. Select Competitors (Total 40 Featured) - Advanced Mobility ProductsAfikim Electric VehiclesAllied VehiclesAMF BrunsAmigo Mobility InternationalAMS VansBraunabilityBrother AutomobilityDrive Devilbiss HealthcareElectric Mobility Euro Read the full report: https://www.reportlinker.com/p06033228/?utm_source=GNW I. METHODOLOGYII. EXECUTIVE SUMMARY1. MARKET OVERVIEW Influencer Market Insights World Market Trajectories Impact of Covid-19 and a Looming Global Recession Global Competitor Market Shares Vehicles for Disabled Competitor Market Share Scenario Worldwide (in %): 2020E Global Competitor Market Shares by Segment 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Vehicles for Disabled by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR Table 2: World Historic Review for Vehicles for Disabled by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR Table 3: World 15-Year Perspective for Vehicles for Disabled by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 Table 4: World Current & Future Analysis for Mobility Scooter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR Table 5: World Historic Review for Mobility Scooter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR Table 6: World 15-Year Perspective for Mobility Scooter by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 7: World Current & Future Analysis for Passenger Cars by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR Table 8: World Historic Review for Passenger Cars by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR Table 9: World 15-Year Perspective for Passenger Cars by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 10: World Current & Future Analysis for SUV / MPV by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR Table 11: World Historic Review for SUV / MPV by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR Table 12: World 15-Year Perspective for SUV / MPV by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 13: World Current & Future Analysis for Pick-Up Truck by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR Table 14: World Historic Review for Pick-Up Truck by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR Table 15: World 15-Year Perspective for Pick-Up Truck by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 III. MARKET ANALYSISUNITED STATES Market Facts & Figures Market Analytics Table 16: USA Current & Future Analysis for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 17: USA Historic Review for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR Table 18: USA 15-Year Perspective for Vehicles for Disabled by End-Use - Percentage Breakdown of Value Sales for Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck for the Years 2012, 2020 & 2027 CANADA Table 19: Canada Current & Future Analysis for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 20: Canada Historic Review for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR Table 21: Canada 15-Year Perspective for Vehicles for Disabled by End-Use - Percentage Breakdown of Value Sales for Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck for the Years 2012, 2020 & 2027 JAPAN Table 22: Japan Current & Future Analysis for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 23: Japan Historic Review for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR Table 24: Japan 15-Year Perspective for Vehicles for Disabled by End-Use - Percentage Breakdown of Value Sales for Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck for the Years 2012, 2020 & 2027 CHINA Table 25: China Current & Future Analysis for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 26: China Historic Review for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR Table 27: China 15-Year Perspective for Vehicles for Disabled by End-Use - Percentage Breakdown of Value Sales for Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck for the Years 2012, 2020 & 2027 EUROPE Market Facts & Figures Market Analytics Table 28: Europe Current & Future Analysis for Vehicles for Disabled by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR Table 29: Europe Historic Review for Vehicles for Disabled by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR Table 30: Europe 15-Year Perspective for Vehicles for Disabled by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 Table 31: Europe Current & Future Analysis for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 32: Europe Historic Review for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR Table 33: Europe 15-Year Perspective for Vehicles for Disabled by End-Use - Percentage Breakdown of Value Sales for Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck for the Years 2012, 2020 & 2027 FRANCE Table 34: France Current & Future Analysis for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 35: France Historic Review for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR Table 36: France 15-Year Perspective for Vehicles for Disabled by End-Use - Percentage Breakdown of Value Sales for Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck for the Years 2012, 2020 & 2027 GERMANY Table 37: Germany Current & Future Analysis for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 38: Germany Historic Review for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR Table 39: Germany 15-Year Perspective for Vehicles for Disabled by End-Use - Percentage Breakdown of Value Sales for Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck for the Years 2012, 2020 & 2027 ITALY Table 40: Italy Current & Future Analysis for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 41: Italy Historic Review for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR Table 42: Italy 15-Year Perspective for Vehicles for Disabled by End-Use - Percentage Breakdown of Value Sales for Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck for the Years 2012, 2020 & 2027 UNITED KINGDOM Table 43: UK Current & Future Analysis for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 44: UK Historic Review for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR Table 45: UK 15-Year Perspective for Vehicles for Disabled by End-Use - Percentage Breakdown of Value Sales for Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck for the Years 2012, 2020 & 2027 REST OF EUROPE Table 46: Rest of Europe Current & Future Analysis for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 47: Rest of Europe Historic Review for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR Table 48: Rest of Europe 15-Year Perspective for Vehicles for Disabled by End-Use - Percentage Breakdown of Value Sales for Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck for the Years 2012, 2020 & 2027 ASIA-PACIFIC Table 49: Asia-Pacific Current & Future Analysis for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 50: Asia-Pacific Historic Review for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR Table 51: Asia-Pacific 15-Year Perspective for Vehicles for Disabled by End-Use - Percentage Breakdown of Value Sales for Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck for the Years 2012, 2020 & 2027 REST OF WORLD Table 52: Rest of World Current & Future Analysis for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 53: Rest of World Historic Review for Vehicles for Disabled by End-Use - Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR Table 54: Rest of World 15-Year Perspective for Vehicles for Disabled by End-Use - Percentage Breakdown of Value Sales for Mobility Scooter, Passenger Cars, SUV / MPV and Pick-Up Truck for the Years 2012, 2020 & 2027 IV. COMPETITIONTotal Companies Profiled: 40Read the full report: https://www.reportlinker.com/p06033228/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
The Prince of Wales chatted to staff from Jesus House where an NHS pop-up vaccine clinic has been set up.
More than half a million people have already signed up on Dr. B, which texts users when there are extra doses nearby in jeopardy of going unused.
The actor who played the lovable but bumbling Jim Trott dies from a dementia-related illness.